Hodgkin lymphoma: highlights from the 2012 European School of Hematology International Conference.

about

Hodgkin lymphoma: highlights from the 2012 European School of Hematology International Conference.

Item

http://www.wikidata.org/entity/Q45825739

description

2013 nî lūn-bûn

@nan

2013年の論文

@ja

2013年学术文章

@wuu

2013年学术文章

@zh

2013年学术文章

@zh-cn

2013年学术文章

@zh-hans

2013年学术文章

@zh-my

2013年学术文章

@zh-sg

2013年學術文章

@yue

2013年學術文章

@zh-hant

name

Hodgkin lymphoma: highlights f ...... logy International Conference.

@en

Hodgkin lymphoma: highlights f ...... logy International Conference.

@nl

type

Item

label

Hodgkin lymphoma: highlights f ...... logy International Conference.

@en

Hodgkin lymphoma: highlights f ...... logy International Conference.

@nl

prefLabel

Hodgkin lymphoma: highlights f ...... logy International Conference.

@en

Hodgkin lymphoma: highlights f ...... logy International Conference.

@nl

P1476

Hodgkin lymphoma: highlights f ...... logy International Conference.

@en

P2093

Angelo Michele Carella

http://www.w3.org/2001/XMLSchema#string

P2860

Tumor-associated macrophages and survival in classic Hodgkin's lymphoma.

Eight cycles of escalated-dose BEACOPP compared with four cycles of escalated-dose BEACOPP followed by four cycles of baseline-dose BEACOPP with or without radiotherapy in patients with advanced-stage hodgkin's lymphoma: final analysis of the HD12 t

Brentuximab vedotin enables successful reduced-intensity allogeneic hematopoietic cell transplantation in patients with relapsed or refractory Hodgkin lymphoma

Results of a pivotal phase II study of brentuximab vedotin for patients with relapsed or refractory Hodgkin's lymphoma

State of the art in the treatment of Hodgkin lymphoma.

FDG-PET after two cycles of chemotherapy predicts treatment failure and progression-free survival in Hodgkin lymphoma.

Reduced-intensity conditioning compared with conventional allogeneic stem-cell transplantation in relapsed or refractory Hodgkin's lymphoma: an analysis from the Lymphoma Working Party of the European Group for Blood and Marrow Transplantation.

P304

35-37

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1586/EHM.12.73

http://www.w3.org/2001/XMLSchema#string

P433

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P577

2013-02-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

235394066

http://www.w3.org/2001/XMLSchema#string

P698

23373777

http://www.w3.org/2001/XMLSchema#string